FDA Inspection
Novo Nordisk A/S - 25a-BFDA Inspection 957571 - Novo Nordisk A/S - 25a-B - January 22, 2016
Record Details
This FDA Inspection record concerns Novo Nordisk A/S - 25a-B, with an inspection on January 22, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Novo Nordisk A/S - 25a-B
- Inspection Date
- January 22, 2016
- Product Type
- Biologics
View Company Profile
ID · a97b3042-eb3e-405d-901c-868c1f2c0ae4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 957571
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Novo Nordisk A/S - 25a-B
7| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2023 | Not classified | Office of Inspections and Investigations | |
| November 4, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 14, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 18, 2015 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| October 10, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novo Nordisk A/S - 25a-B
- FDA Inspection 1223821 - 2023-11-07
- FDA Inspection 1207487 - 2022-11-04
- FDA Inspection 1118196 - 2018-06-14
- FDA Inspection 933969 - 2015-06-18
- FDA Inspection 909374 - 2014-10-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.